Compare PTCT & AVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTCT | AVT |
|---|---|---|
| Founded | 1998 | 1921 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 7.1B |
| IPO Year | 2006 | 1994 |
| Metric | PTCT | AVT |
|---|---|---|
| Price | $76.82 | $89.42 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 3 |
| Target Price | ★ $80.65 | $59.33 |
| AVG Volume (30 Days) | ★ 1.5M | 1.0M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.72% |
| EPS Growth | ★ 264.48 | N/A |
| EPS | N/A | ★ 2.49 |
| Revenue | $264,734,000.00 | ★ $22,200,754,000.00 |
| Revenue This Year | N/A | $14.39 |
| Revenue Next Year | $17.70 | $5.44 |
| P/E Ratio | ★ N/A | $36.11 |
| Revenue Growth | ★ 36.19 | N/A |
| 52 Week Low | $43.18 | $44.25 |
| 52 Week High | $90.87 | $95.26 |
| Indicator | PTCT | AVT |
|---|---|---|
| Relative Strength Index (RSI) | 43.24 | 54.16 |
| Support Level | $74.45 | $81.80 |
| Resistance Level | $79.67 | $95.26 |
| Average True Range (ATR) | 3.27 | 2.45 |
| MACD | -1.01 | 0.45 |
| Stochastic Oscillator | 4.47 | 75.69 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Avnet Inc is an electronic component technology distributor and solutions provider. It serves customers from startups and mid-sized businesses to enterprise-level original equipment manufacturers (OEMs), electronic manufacturing services (EMS) providers, and original design manufacturers (ODMs). The group operates in the Electronic Components segment and supports high and medium-volume customers to markets, sells, and distributes electronic components, and the Farnell segment supports lower-volume customers that need electronic components quickly to develop, prototype, and test their products. Its geographic regions are the Americas, EMEA, and Asia.